[1]. Go, A.S., et al., Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation, 2014. 129(3): p. e28-e292.
[2]. Ju, Y., et al., Neurological deterioration in the acute phase of minor ischemic stroke is an independent predictor of poor outcomes at 1 year: results from the China National Stroke Registry (CNSR). Chin Med J (Engl), 2013. 126(18): p. 3411-6.
[3]Rothwell P M , Giles M F , Chandratheva A , et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison[J]. The Lancet, 2007, 370(9596):0-1442.
[4].Ois, A., et al., Factors Associated With a High Risk of Recurrence in Patients With Transient Ischemic Attack or Minor Stroke. Stroke, 2008. 39(6): p. 1717-1721.
[5]. Romano, J.G., et al., Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines-Stroke registry. JAMA Neurol, 2015. 72(4): p. 423-31.
[6]. Leira, E.C., et al., The types of neurological deficits might not justify withholding treatment in patients with low total National Institutes of Health Stroke Scale scores. Stroke, 2012. 43(3): p. 782-6.
[7]. Chang, B., et al., A Prognostic Nomogram Incorporating Depth of Tumor Invasion to Predict Long-term Overall Survival for Tongue Squamous Cell Carcinoma With R0 Resection. Journal of Cancer, 2018. 9(12): p. 2107-2115.
[8]. Callegaro, D., et al., Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis. LANCET ONCOLOGY, 2016. 17(5): p. 671-680.
[9]. Yinlong Wang,et al, Guidelines for the diagnosis and treatment of high-risk non-disabling ischemic cerebrovascular events.Chinese Journal of Stroke, 2016. 11(06): p.481-491.
[10]. Akaike, H., Information Theory and an Extension of the Maximum Likelihood Principle, in Selected Papers of Hirotugu Akaike, E. Parzen, K. Tanabe and G. Kitagawa, E. Parzen, K. Tanabe and G. Kitagawa^Editors. 1998, Springer New York: New York, NY. p. 199-213.
[11]. Kleindorfer, D., et al., Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke, 2005. 36(4): p. 720-3.
[12]. Kernan, W.N., et al., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 2014. 45(7): p. 2160-236.
[13]. Lee, E., et al., Mortality and causes of death in patients with atrial fibrillation: A nationwide population-based study. PLoS One, 2018. 13(12): p. e0209687.
[14]. Lewington, S., et al., Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet, 2002. 360(9349): p. 1903-13.
[15]. Tan, Z., et al., Blood pressure variability estimated by ARV is a predictor of poor short-term outcomes in a prospective cohort of minor ischemic stroke. PLOS ONE, 2018. 13(8): p. e0202317.
[16]. Tao, X., et al., Lower Serum Indirect Bilirubin Levels are Inversely Related to Carotid Intima-Media Thickness Progression. Curr Neurovasc Res, 2019. 16(2): p. 148-155.
[17]. Li, R., et al., The role of uric acid as a potential neuroprotectant in acute ischemic stroke: a review of literature. Neurol Sci, 2015. 36(7): p. 1097-103.
[18]. Zhang, B., et al., Suitable Concentrations of Uric Acid Can Reduce Cell Death in Models of OGD and Cerebral Ischemia-Reperfusion Injury. Cell Mol Neurobiol, 2017. 37(5): p. 931-939.
[19]. Zhang, B., et al., Is elevated SUA associated with a worse outcome in young Chinese patients with acute cerebral ischemic stroke? BMC Neurol, 2010. 10: p. 82.
[20]. Wang, Z., et al., Serum Uric Acid Levels and Outcomes After Acute Ischemic Stroke. Mol Neurobiol, 2016. 53(3): p. 1753-1759.
[21]. Davalos, A., et al., Body iron stores and early neurologic deterioration in acute cerebral infarction. Neurology, 2000. 54(8): p. 1568-74.
[22]Maruhashi T , Kihara Y , Higashi Y . Bilirubin and Endothelial Function[J]. Journal of Atherosclerosis & Thrombosis, 2019, 26(8).
[23]. Li, R.Y., et al., Decreased serum bilirubin is associated with silent cerebral infarction. Arterioscler Thromb Vasc Biol, 2014. 34(4): p. 946-51.
[24]. Heron, N., et al., Secondary prevention lifestyle interventions initiated within 90 days after TIA or 'minor' stroke: a systematic review and meta-analysis of rehabilitation programmes. Br J Gen Pract, 2017. 67(654): p. e57-e66.
[25]. Ahmadi, M., et al., A support programme for secondary prevention in patients with transient ischaemic attack and minor stroke (INSPiRE-TMS): an open-label, randomised controlled trial. Lancet Neurol, 2020. 19(1): p. 49-60.
[26]. Rempe, D.A., Predicting Outcomes After Transient Ischemic Attack and Stroke. CONTINUUM: Lifelong Learning in Neurology, 2014. 20(2, Cerebrovascular Disease): p. 412-428.
[27]. Rempe, D.A., Predicting outcomes after transient ischemic attack and stroke. Continuum (Minneap Minn), 2014. 20(2 Cerebrovascular Disease): p. 412-28.